search
attachments
weblink
advanced
Overview
Content Tools
Tasks
DATE : 2013-10-30
Bayer CropScience received an Agrow Award for its herbicidal active ingredient indaziflam in the category Best New Crop Protection Product . Marketed under brand names such as Alion , Specticle and Esplanade products based on indaziflam offer new tools to control a broad spectrum of weeds in agricultural crops as well as in turf, home and garden, forestry and industrial vegetation management market segments.
We are incredibly honored to receive this prestigeous award, said Dr. Hermann Stübler, Head of Weed Control Research at Bayer CropScience at the award ceremony in Amsterdam (Netherlands) on Monday October 28th. The need for new herbicides with alternative modes of action and resistance breaking capabilities is more urgent than ever. In a team effort we created and developed indaziflam, employing our leading expertise in herbicide research and our deep knowledge of weed control.
The non-selective herbicide Alion was developed primarily for use in perennial crops such as citrus, tree nut, grapes, pome and stone fruit, and multiyear sugarcane. Furthermore, Alion is an effective tool to manage weed populations that are resistant to other modes of action. Specticle is available for professional users operating in the commercially important turf segment. Esplande was successfully launched into the industrial vegetation management segments and is about to be launched into the forestry segment. As a continuous-action weed and grass barrier, indaziflam is also available to private consumers in North America in the lawn care segment (DuraZone ).
Indaziflam belongs to the chemical class of alkylazines. The new compound controls a broad spectrum of weeds and provides excellent long-lasting efficacy at low application rates. This makes indaziflam an environmentally compatible and pioneering active ingredient in the global herbicides market.
The prestigious Agrow Awards, presented by Agrow, a leading information provider for the global crop protection industry, provide the industry with the opportunity to showcase its innovative excellence. The awards feature 15 categories in areas such as R&D, formulation technology, packaging innovation, stewardship, marketing, business strategy and corporate responsibility with entries being judged by an independent panel of industry experts.
SOURCE Mena Report
Bayer CropScience received an Agrow Award for its herbicidal active ingredient indaziflam in the category Best New Crop Protection Product . Marketed under brand names such as Alion , Specticle and Esplanade products based on indaziflam offer new tools to control a broad spectrum of weeds in agricultural crops as well as in turf, home and garden, forestry and industrial vegetation management market segments.
We are incredibly honored to receive this prestigeous award, said Dr. Hermann Stübler, Head of Weed Control Research at Bayer CropScience at the award ceremony in Amsterdam (Netherlands) on Monday October 28th. The need for new herbicides with alternative modes of action and resistance breaking capabilities is more urgent than ever. In a team effort we created and developed indaziflam, employing our leading expertise in herbicide research and our deep knowledge of weed control.
The non-selective herbicide Alion was developed primarily for use in perennial crops such as citrus, tree nut, grapes, pome and stone fruit, and multiyear sugarcane. Furthermore, Alion is an effective tool to manage weed populations that are resistant to other modes of action. Specticle is available for professional users operating in the commercially important turf segment. Esplande was successfully launched into the industrial vegetation management segments and is about to be launched into the forestry segment. As a continuous-action weed and grass barrier, indaziflam is also available to private consumers in North America in the lawn care segment (DuraZone ).
Indaziflam belongs to the chemical class of alkylazines. The new compound controls a broad spectrum of weeds and provides excellent long-lasting efficacy at low application rates. This makes indaziflam an environmentally compatible and pioneering active ingredient in the global herbicides market.
The prestigious Agrow Awards, presented by Agrow, a leading information provider for the global crop protection industry, provide the industry with the opportunity to showcase its innovative excellence. The awards feature 15 categories in areas such as R&D, formulation technology, packaging innovation, stewardship, marketing, business strategy and corporate responsibility with entries being judged by an independent panel of industry experts.
SOURCE Mena Report
DATE : 2013-10-30
PTT Asahi restarted its acrylonitrile (ACN) plant. A Polymerupdate source in Thailand informed that the plant restarted on October 23, 2013. It was shut on September 25, 2013 owing to mechanical issues.
Located at Map Ta Phut, Thailand, the plant has a production capacity of 200,000 mt/year.
SOURCE PolymerUpdate
PTT Asahi restarted its acrylonitrile (ACN) plant. A Polymerupdate source in Thailand informed that the plant restarted on October 23, 2013. It was shut on September 25, 2013 owing to mechanical issues.
Located at Map Ta Phut, Thailand, the plant has a production capacity of 200,000 mt/year.
SOURCE PolymerUpdate
DATE : 2013-10-30
Grand Pacific Petrochemical Corp (GPPC) is likely to shut its styrene monomer (SM) plant for maintenance turnaround. A Polymerupdate source in Taiwan informed that the plant is likely to be shut in mid-February 2014.
It will remain off-stream for around one month.Located in Tashe, Taiwan, the plant has a production capacity of 130,000 mt/year.
SOURCE Polymer Update
Grand Pacific Petrochemical Corp (GPPC) is likely to shut its styrene monomer (SM) plant for maintenance turnaround. A Polymerupdate source in Taiwan informed that the plant is likely to be shut in mid-February 2014.
It will remain off-stream for around one month.Located in Tashe, Taiwan, the plant has a production capacity of 130,000 mt/year.
SOURCE Polymer Update
DATE : 2013-10-29
China’s Shanghai Huayi Acrylic Acid plans to start up a 320,000 tonne/year acrylic acid (AA) facility in Caojing, Shanghai, in 2015, a company source said on Tuesday.
A 160,000 tonne/year line at the facility will begin operations in early 2015, while the second line of a similar capacity will start up in the second half, she said.
The company’s existing 230,000 tonnes/year AA plant at Gaoqiao, Shanghai, will eventually be shut permanently to free up the land for alternative uses but a specific timeline has yet to be set, she said.
A 40,000 tonne/year line at the Gaoqiao plant has been offline since June following an explosion, according to the source.
The other three lines at the Gaoqiao plant that are currently operating have a combined capacity of 190,000 tonnes/year, the source added.
SOURCE Icis News
China’s Shanghai Huayi Acrylic Acid plans to start up a 320,000 tonne/year acrylic acid (AA) facility in Caojing, Shanghai, in 2015, a company source said on Tuesday.
A 160,000 tonne/year line at the facility will begin operations in early 2015, while the second line of a similar capacity will start up in the second half, she said.
The company’s existing 230,000 tonnes/year AA plant at Gaoqiao, Shanghai, will eventually be shut permanently to free up the land for alternative uses but a specific timeline has yet to be set, she said.
A 40,000 tonne/year line at the Gaoqiao plant has been offline since June following an explosion, according to the source.
The other three lines at the Gaoqiao plant that are currently operating have a combined capacity of 190,000 tonnes/year, the source added.
SOURCE Icis News
DATE : 2013-10-28
EnerSys, the global leader in stored energy solutions for industrial applications, today announced that it has entered into an agreement to acquire Quallion LLC, a manufacturer of lithium ion cells and batteries for high integrity applications for $30 million. Headquartered in Sylmar, CA, Quallion's products include lithium ion cells and batteries for diverse applications including medical devices, defense, aviation and space. The closing of the transaction is subject to customary closing conditions.
"This acquisition provides EnerSys with an entry into the rapidly growing medical device battery markets for both implantable and external devices," said John D. Craig, chairman, president and chief executive officer of EnerSys. "With the United States government's Title III investment of $65 million in Quallion's cathode and anode production equipment, we will have the capability to produce lithium ion materials and for satellite batteries. In addition to being the only domestic battery manufacturer to control the complete production process, by combining Quallion with our ABSL space business, EnerSys becomes the largest domestic provider of battery technology to the space industry. We anticipate that this transaction will be accretive to our earnings by 3 to 5 cents per diluted share during the first full year following acquisition."
EnerSys, the global leader in stored energy solutions for industrial applications, manufactures and distributes reserve power and motive power batteries, chargers, power equipment, and battery accessories to customers worldwide. Motive power batteries are utilized in electric fork trucks and other commercial electric powered vehicles. Reserve power batteries are used in the telecommunications and utility industries, uninterruptible power supplies, and numerous applications requiring standby power. The company also provides aftermarket and customer support services to its customers from over 100 countries through its sales and manufacturing locations around the world.
More information regarding EnerSys can be found at www.enersys.com.
Quallion designs, fabricates and manufactures state-of-the-art lithium ion cells and battery packs, and develops new battery chemistries for the military, aerospace, medical and automotive industries. Building on its legacy leadership position in the medical device industry, the company has developed a range of novel enabling technologies that includes the world's smallest implantable secondary battery and the proprietary Zero-Volt ™ and SaFE-LYTE ™ technologies. Leveraging its core engineering capabilities, Quallion has established itself as a leader in applications where advanced battery technology, safety, reliability and custom engineering are most valued. Quallion LLC was founded in 1998.
SOURCE PR Newswire
EnerSys, the global leader in stored energy solutions for industrial applications, today announced that it has entered into an agreement to acquire Quallion LLC, a manufacturer of lithium ion cells and batteries for high integrity applications for $30 million. Headquartered in Sylmar, CA, Quallion's products include lithium ion cells and batteries for diverse applications including medical devices, defense, aviation and space. The closing of the transaction is subject to customary closing conditions.
"This acquisition provides EnerSys with an entry into the rapidly growing medical device battery markets for both implantable and external devices," said John D. Craig, chairman, president and chief executive officer of EnerSys. "With the United States government's Title III investment of $65 million in Quallion's cathode and anode production equipment, we will have the capability to produce lithium ion materials and for satellite batteries. In addition to being the only domestic battery manufacturer to control the complete production process, by combining Quallion with our ABSL space business, EnerSys becomes the largest domestic provider of battery technology to the space industry. We anticipate that this transaction will be accretive to our earnings by 3 to 5 cents per diluted share during the first full year following acquisition."
EnerSys, the global leader in stored energy solutions for industrial applications, manufactures and distributes reserve power and motive power batteries, chargers, power equipment, and battery accessories to customers worldwide. Motive power batteries are utilized in electric fork trucks and other commercial electric powered vehicles. Reserve power batteries are used in the telecommunications and utility industries, uninterruptible power supplies, and numerous applications requiring standby power. The company also provides aftermarket and customer support services to its customers from over 100 countries through its sales and manufacturing locations around the world.
More information regarding EnerSys can be found at www.enersys.com.
Quallion designs, fabricates and manufactures state-of-the-art lithium ion cells and battery packs, and develops new battery chemistries for the military, aerospace, medical and automotive industries. Building on its legacy leadership position in the medical device industry, the company has developed a range of novel enabling technologies that includes the world's smallest implantable secondary battery and the proprietary Zero-Volt ™ and SaFE-LYTE ™ technologies. Leveraging its core engineering capabilities, Quallion has established itself as a leader in applications where advanced battery technology, safety, reliability and custom engineering are most valued. Quallion LLC was founded in 1998.
SOURCE PR Newswire
DATE : 2013-10-29
China's Shangdong Kaitai Petrochemical Co Ltd started up its new 80,000 tonne/year butyl acrylate (butyl-A) plant in Shandong province on 28 October, a company source said on Tuesday.
It also brought its new 80,000 tonne/year crude acrylic acid plant on stream on the same day, the source said without disclosing the current run rates of the two plants.
Industry sources expect the company to start supplying butyl-A and AA to the domestic market by the end of the week.
Butyl-A prices in the Chinese market were assessed at yuan (CNY) 15,400-15,500/tonne ($2,529-2,545/tonne) DEL (delivered) east China on 28 October, unchanged from last week, according to Chemease, an ICIS service in China.
While butyl-A market prices were assessed at $1,950-2,030/tonne CIF (Cost Insurance and Freight) China on 23 October, according to ICIS.
Shangdong Kaitai Petrochemical has an old acrylic acid plant with a 30,000 tonne/year capacity and a 5,000 tonne/year methyl acrylate (methyl-A) unit, according to the company source.
The company was formerly known as Shandong Qilu Petrochemical Kaitai Industrial Ltd.
SOURCE Icis News
China's Shangdong Kaitai Petrochemical Co Ltd started up its new 80,000 tonne/year butyl acrylate (butyl-A) plant in Shandong province on 28 October, a company source said on Tuesday.
It also brought its new 80,000 tonne/year crude acrylic acid plant on stream on the same day, the source said without disclosing the current run rates of the two plants.
Industry sources expect the company to start supplying butyl-A and AA to the domestic market by the end of the week.
Butyl-A prices in the Chinese market were assessed at yuan (CNY) 15,400-15,500/tonne ($2,529-2,545/tonne) DEL (delivered) east China on 28 October, unchanged from last week, according to Chemease, an ICIS service in China.
While butyl-A market prices were assessed at $1,950-2,030/tonne CIF (Cost Insurance and Freight) China on 23 October, according to ICIS.
Shangdong Kaitai Petrochemical has an old acrylic acid plant with a 30,000 tonne/year capacity and a 5,000 tonne/year methyl acrylate (methyl-A) unit, according to the company source.
The company was formerly known as Shandong Qilu Petrochemical Kaitai Industrial Ltd.
SOURCE Icis News
Zurich (awp) - La filiale japonaise de Roche, Chugai, prévoit de produire moins de vaccins Tamiflu pour la saison de la grippe 2013/2014. Elle pense préparer au total 8,0 mio unités de traitement, 5 mio sous forme de gélules et 3 mio sous forme de sirop, a-t-elle indiqué jeudi.
Cette prévision est nettement inférieure aux chiffres de l'année précédente. Début novembre 2012, la société avait avancé le chiffre de 11 mio de vaccins, 8 mio sous formes de gélules et 3 mio sous forme de sirop.
Sur les neuf premiers mois 2013, Roche a réalisé un chiffre d'affaires de 414 mio CHF avec Tamiflu, en hausse de 81% sur un an, comme l'a annoncé jeudi dernier le groupe pharmaceutique lors de la publication de son rapport intermédiaire.
A cette occasion, le CEO Severin Schwan a indiqué que la grande inconnue en fin d'année portera sur les ventes de Tamiflu, rappelant qu'au dernier trimestre 2012, le vaccin contre la grippe avait généré un chiffre d'affaires conséquent. Sur l'ensemble de l'exercice 2012, les ventes s'étaient inscrites à 560 mio CHF.
DATE : 2013-10-25
Un additif alimentaire très répandu semble empêcher une nouvelle souche de la grippe aviaire d'infecter les cellules en santé, indique une étude réalisée par des chercheurs de l'Université de l'Illinois.
L'hydroquinone de tert-butyle est utilisée comme préservatif. Lors de tests en laboratoire, le produit, auquel on connaissait déjà des propriétés antivirales, s'est attaqué à une portion du virus H7N9 laissée de côté par les autres thérapies, ce qui permet de croire à son efficacité face aux souches multirésistantes.
Le chercheur Michael Caffrey a rappelé qu'une récente éclosion de H7N9 en Chine a eu un taux de mortalité de 20% et que le virus donne déjà des signes de pharmacorésistance, d'où l'urgence de développer de nouvelles thérapies antivirales.
L'hydroquinone de tert-butyle empêche le virus d'utiliser une protéine appelée hémagglutinine pour pénétrer à l'intérieur des cellules, rendant leur infection impossible.
Les chercheurs tentent maintenant de rehausser les propriétés antivirales de l'hydroquinone de tert-butyle. Ils envisagent notamment de l'ajouter à l'alimentation des volailles, puisqu'en empêchant la propagation du virus parmi les oiseaux on pourrait ensuite réduire les risques de transmission à l'homme.
Des doutes subsistent toutefois quant à l'innocuité de l'hydroquinone de tert-butyle lorsque consommée en grandes quantités.
Les résultats de cette étude sont dévoilés dans le journal en ligne PLOS ONE.
SOURCE La Presse Canadienne
DATE : 2013-10-25
The closure of INEOS' plant in the UK and Celanese's facility in Spain will cut supplies but imports will rise. “Structurally the market is long and will remain long. I do not think there is going to be a big impact on the European market”. Several participants in the vinyl acetate monomer (VAM) market expect the closure of INEOS’s Hull VAM plant in the UK to have only a limited impact on the European market.
Speaking on the sidelines of the 47th annual European Petrochemical Association (EPCA) meeting, a reseller of Asian material said that news of the closure had not come as a surprise, given the producer’s cost issues and previous technical problems.
VAM imports will increase as a result, the source said, and should be sufficient to satisfy demand, which is not especially high. However, the reseller noted that imports from the US and Saudi Arabia will not be enough. “I see an option in Asia”, the source said, adding that “what is clear to me is that prices for VAM are going north.”
A buyer in southern Europe said that the closure of the Hull plant alone would not have a major impact, but the potential closure of Celanese's plant in Tarragona, Spain, would mean a combined loss of 350,000 tonnes/year of VAM sales into the European market.
Celanese announced in May that it was seeking buyers for its 200,000 tonne/year VAM plant in Tarragona, explaining that its strategy favours integrated production sites that provide economies of scale.
“Next year could be very messy for VAM. Not because of price but because of supply,” the buyer said.
Another buyer said the announcement was a surprise, considering that INEOS had invested heavily in the facility. A major consumer said that it was not especially concerned about the planned closure of the Hull unit.
“It’s no surprise. The timing is more surprising,” the source said, acknowledging that “there is a bit of a psychological impact.”
“Structurally the market is long and will remain long,” the source said. “I do not think there is going to be a big impact on the European market.”
The VAM market has been well-supplied throughout 2013, with demand from many downstream sectors being lacklustre.
INEOS Enterprises announced on 4 October that it would close its Hull VAM plant with the loss of 18 jobs, saying that low-cost imports and a hostile trading environment made closure inevitable. The date on which the plant will cease operations was not disclosed. The plant has 300,000 tonnes/year of nameplate capacity. The producer explained in its statement that the VAM market has become increasingly targeted by cheap imports, mainly from Saudi Arabia and the US, both of which benefit from low-cost raw materials.
INEOS Enterprises acquired the plant from BP in April 2008. The unit was built in 2002 and was the first plant capable of producing 300,000 tonnes/year in a single train reactor.
SOURCE Icis News
The closure of INEOS' plant in the UK and Celanese's facility in Spain will cut supplies but imports will rise. “Structurally the market is long and will remain long. I do not think there is going to be a big impact on the European market”. Several participants in the vinyl acetate monomer (VAM) market expect the closure of INEOS’s Hull VAM plant in the UK to have only a limited impact on the European market.
Speaking on the sidelines of the 47th annual European Petrochemical Association (EPCA) meeting, a reseller of Asian material said that news of the closure had not come as a surprise, given the producer’s cost issues and previous technical problems.
VAM imports will increase as a result, the source said, and should be sufficient to satisfy demand, which is not especially high. However, the reseller noted that imports from the US and Saudi Arabia will not be enough. “I see an option in Asia”, the source said, adding that “what is clear to me is that prices for VAM are going north.”
A buyer in southern Europe said that the closure of the Hull plant alone would not have a major impact, but the potential closure of Celanese's plant in Tarragona, Spain, would mean a combined loss of 350,000 tonnes/year of VAM sales into the European market.
Celanese announced in May that it was seeking buyers for its 200,000 tonne/year VAM plant in Tarragona, explaining that its strategy favours integrated production sites that provide economies of scale.
“Next year could be very messy for VAM. Not because of price but because of supply,” the buyer said.
Another buyer said the announcement was a surprise, considering that INEOS had invested heavily in the facility. A major consumer said that it was not especially concerned about the planned closure of the Hull unit.
“It’s no surprise. The timing is more surprising,” the source said, acknowledging that “there is a bit of a psychological impact.”
“Structurally the market is long and will remain long,” the source said. “I do not think there is going to be a big impact on the European market.”
The VAM market has been well-supplied throughout 2013, with demand from many downstream sectors being lacklustre.
INEOS Enterprises announced on 4 October that it would close its Hull VAM plant with the loss of 18 jobs, saying that low-cost imports and a hostile trading environment made closure inevitable. The date on which the plant will cease operations was not disclosed. The plant has 300,000 tonnes/year of nameplate capacity. The producer explained in its statement that the VAM market has become increasingly targeted by cheap imports, mainly from Saudi Arabia and the US, both of which benefit from low-cost raw materials.
INEOS Enterprises acquired the plant from BP in April 2008. The unit was built in 2002 and was the first plant capable of producing 300,000 tonnes/year in a single train reactor.
SOURCE Icis News
DATE : 2013-10-25
Japan-based Dia-Nitrix Co. Ltd., which engages in an integrated chain of acrylonitrile (ACN) business operations, would be closing its two ACN plants next year for maintenance turnaround.
The company operates an 115,000 mt/year ACN pant in Mizushima and another 90,000 mt/year plant in Otake.
“The Mizushima plant is tentatively scheduled to be shut for maintenance turnaround in mid-February 2014, and it is likely to stay off-stream till the beginning of April,” a company official told fibre2fashion.
When asked about the Otake-based plant, the official said, it is likely to be shut for maintenance in the end of September 2014 and it would be restarted in November 2014.
Dia-Nitrix was established in July 2001 as a joint venture between Mitsubishi Rayon Co., Ltd. and Mitsubishi Chemical Corp.
Acrylonitrile is mainly used in the manufacture of acrylic fibres for the textiles and clothing industry.
SOURCE Fibre2Fashion
Japan-based Dia-Nitrix Co. Ltd., which engages in an integrated chain of acrylonitrile (ACN) business operations, would be closing its two ACN plants next year for maintenance turnaround.
The company operates an 115,000 mt/year ACN pant in Mizushima and another 90,000 mt/year plant in Otake.
“The Mizushima plant is tentatively scheduled to be shut for maintenance turnaround in mid-February 2014, and it is likely to stay off-stream till the beginning of April,” a company official told fibre2fashion.
When asked about the Otake-based plant, the official said, it is likely to be shut for maintenance in the end of September 2014 and it would be restarted in November 2014.
Dia-Nitrix was established in July 2001 as a joint venture between Mitsubishi Rayon Co., Ltd. and Mitsubishi Chemical Corp.
Acrylonitrile is mainly used in the manufacture of acrylic fibres for the textiles and clothing industry.
SOURCE Fibre2Fashion
DATE : 2013-10-25
Global acrylonitrile (ACN) consumption in 2014 is expected to grow by 2% compared with 2013, depending on the performance of acrylonitrile-butadiene-styrene (ABS), sources said on Friday.
ABS growth in China is seen as the key driver for growth in 2014. This will in turn depend on macroeconomic conditions.
“2014 - 2% growth could be correct. ABS - how that will be doing is the main issue,” a European producer said.
ABS growth is being buoyed by megatrends such as light-weighting of cars, construction increases in china, and an expansion of automobile ownership due to upward social mobility in developing countries.
Global automobile ownership has been forecast to double by 2020.
Nevertheless, growth forecasts for 2014 are more cautious than those in the past.
“[the growth forecasts are] almost a slight increase, not like 2010 and 2011... Those numbers are relatively pessimistic compared to the ones in the past. Demand is still growing. It's ABS in China,” a global distributor said.
Not all ACN sources are optimistic about demand in 2014. Global fibre demand in 2014 is expected to remain at parity with 2013, a major acrylic fibre producer said.
“2014 - there's no reason to estimate the world is getting better. We make a modest budget and try to be inline and at least break-even,” the acrylic fibre producer said.
SOURCE Icis News
Global acrylonitrile (ACN) consumption in 2014 is expected to grow by 2% compared with 2013, depending on the performance of acrylonitrile-butadiene-styrene (ABS), sources said on Friday.
ABS growth in China is seen as the key driver for growth in 2014. This will in turn depend on macroeconomic conditions.
“2014 - 2% growth could be correct. ABS - how that will be doing is the main issue,” a European producer said.
ABS growth is being buoyed by megatrends such as light-weighting of cars, construction increases in china, and an expansion of automobile ownership due to upward social mobility in developing countries.
Global automobile ownership has been forecast to double by 2020.
Nevertheless, growth forecasts for 2014 are more cautious than those in the past.
“[the growth forecasts are] almost a slight increase, not like 2010 and 2011... Those numbers are relatively pessimistic compared to the ones in the past. Demand is still growing. It's ABS in China,” a global distributor said.
Not all ACN sources are optimistic about demand in 2014. Global fibre demand in 2014 is expected to remain at parity with 2013, a major acrylic fibre producer said.
“2014 - there's no reason to estimate the world is getting better. We make a modest budget and try to be inline and at least break-even,” the acrylic fibre producer said.
SOURCE Icis News
DATE : 2013-10-23
South Korea’s Samsung Total Petrochemical plans to shut its 650,000 tonne/year styrene monomer (SM) unit in March 2014 for maintenance, a company source said on the sidelines of the CBI Styrene conference on Wednesday.
The unit, at Daesan, is expected to be shut for around three weeks, the source added.
The company operates another 280,000 tonne/year SM unit at the same location. That unit will operate normally during this time.
SOURCE Icis News
South Korea’s Samsung Total Petrochemical plans to shut its 650,000 tonne/year styrene monomer (SM) unit in March 2014 for maintenance, a company source said on the sidelines of the CBI Styrene conference on Wednesday.
The unit, at Daesan, is expected to be shut for around three weeks, the source added.
The company operates another 280,000 tonne/year SM unit at the same location. That unit will operate normally during this time.
SOURCE Icis News
DATE : 2013-10-25
Taiwan Styrene Monomer Co (TSMC) is in plans to shut is No.2 styrene monomer (SM) plant for maintenance turnaround.
A Polymerupdate source in Taiwan informed that the plant is likely to be shut in May 2014. It is planned to remain offstream for around 1 month.
Located in Linyuan, Taiwan, the plant has a production capacity of 160,000 mt/year.
SOURCE PolymerUpdate
Taiwan Styrene Monomer Co (TSMC) is in plans to shut is No.2 styrene monomer (SM) plant for maintenance turnaround.
A Polymerupdate source in Taiwan informed that the plant is likely to be shut in May 2014. It is planned to remain offstream for around 1 month.
Located in Linyuan, Taiwan, the plant has a production capacity of 160,000 mt/year.
SOURCE PolymerUpdate
DATE : 2013-10-23
Japan’s Asahi Kasei Chemical plans to shut its styrene monomer (SM) units in February next year for maintenance, a company source said on the sidelines of the CBI Styrene conference on Wednesday.
The 320,000 tonne/year No2 unit at Mizushima is scheduled to shut from mid February for two months. The 390,000 tonne/year No3 unit at the same location will be shut for maintenance for the month of March.
The company’s No 1 plant was mothballed in 2007.
Other Japanese SM producers include Idemitsu Kosan, Denka and Nihon Oxirane.
SOURCE Icis News
Japan’s Asahi Kasei Chemical plans to shut its styrene monomer (SM) units in February next year for maintenance, a company source said on the sidelines of the CBI Styrene conference on Wednesday.
The 320,000 tonne/year No2 unit at Mizushima is scheduled to shut from mid February for two months. The 390,000 tonne/year No3 unit at the same location will be shut for maintenance for the month of March.
The company’s No 1 plant was mothballed in 2007.
Other Japanese SM producers include Idemitsu Kosan, Denka and Nihon Oxirane.
SOURCE Icis News
DATE : 2013-10-23
Japan-based chemicals producer Nippon Shokubai has started commercial production at its new 80,000 tonne/year acrylic acid (AA) and 90,000 tonne/year super absorbent polymer (SAP) plants at Cilegon, Indonesia, the producer said on Wednesday.
PT Nippon Shokubai Indonesia, the wholly-owned subsidiary that runs the plants, held an inaugural ceremony at the site on Wednesday, the company said.
The start-up of the new plants has raised Nippon Shokubai’s total acrylic acid capacity to 700,000 tonnes/year, and SAP capacity to 560,000 tonnes/year, the company said.
The mechanical completion of the AA and SAP plants, which together cost $300m, was in March 2013, according to Nippon Shokubai.
SOURCE Icis News
Japan-based chemicals producer Nippon Shokubai has started commercial production at its new 80,000 tonne/year acrylic acid (AA) and 90,000 tonne/year super absorbent polymer (SAP) plants at Cilegon, Indonesia, the producer said on Wednesday.
PT Nippon Shokubai Indonesia, the wholly-owned subsidiary that runs the plants, held an inaugural ceremony at the site on Wednesday, the company said.
The start-up of the new plants has raised Nippon Shokubai’s total acrylic acid capacity to 700,000 tonnes/year, and SAP capacity to 560,000 tonnes/year, the company said.
The mechanical completion of the AA and SAP plants, which together cost $300m, was in March 2013, according to Nippon Shokubai.
SOURCE Icis News